Eli Lilly and Company(@EliLillyandCo):The @US_FDA has approved a new dosing option for Lilly’s moderate-to-severe atopic dermatitis (#eczema) treatment. Learn more about what this may mean for patients: https://t.co/JHc16JSo5u

Eli Lilly and Company

@EliLillyandCo

Uniting caring with discovery to create medicines that make life better worldwide. Lilly’s official account (formerly LillyPad)

加入 July 2010

1.2K 正在关注 146.1K 粉丝

Eli Lilly and Company@EliLillyandCo

2026.06.10 01:29

The @US_FDA has approved a new dosing option for Lilly’s moderate-to-severe atopic dermatitis (#eczema#) treatment. Learn more about what this may mean for patients:

显示更多

转发到社区

热门用户

0 粉丝

4.2M 粉丝

1.9M 粉丝

181.5K 粉丝

26.4M 粉丝

569.3K 粉丝

256.8K 粉丝

100.9K 粉丝

0 粉丝

16.8M 粉丝

34.2K 粉丝

130K 粉丝

547.7K 粉丝

10.5M 粉丝

348.9K 粉丝